유원상

유원상 (chief executive) discloses dealings in 유유제약 to DART (FSS). In total, 65 filings cover trades dated from 5 April 2021 to 21 July 2026.

On the open market, the record shows 5 purchases and 1 sale. The totals do not cover 6 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2026: 1 purchase and 1 sale on the market.

The 5 purchases reviewed show no overlap with other insiders buying the same stock within a month.

Most recently, on 21 July 2026, the filings show a transaction in 유유제약. The most recent open-market purchase was published on 3 February 2026, 257 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from DART (FSS). Past trades are no guide to future returns.